<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Experimental and epidemiologic studies have indicated a link between the dietary consumption of xanthophyll carotenoids, i.e., lutein (L) and zeaxanthin (Z), or n-3 PUFAs and the reduced risk of advanced AMD [
 <xref rid="B187-marinedrugs-17-00374" ref-type="bibr" class="xref">187</xref>,
 <xref rid="B188-marinedrugs-17-00374" ref-type="bibr" class="xref">188</xref>,
 <xref rid="B189-marinedrugs-17-00374" ref-type="bibr" class="xref">189</xref>,
 <xref rid="B190-marinedrugs-17-00374" ref-type="bibr" class="xref">190</xref>,
 <xref rid="B191-marinedrugs-17-00374" ref-type="bibr" class="xref">191</xref>]. Specifically, they found a direct correlation between the daily intake of these xanthophyll carotenoids and their concentrations in both plasma and macula, the latter being the district were they used to synthetize the macular pigment [
 <xref rid="B192-marinedrugs-17-00374" ref-type="bibr" class="xref">192</xref>,
 <xref rid="B193-marinedrugs-17-00374" ref-type="bibr" class="xref">193</xref>,
 <xref rid="B194-marinedrugs-17-00374" ref-type="bibr" class="xref">194</xref>,
 <xref rid="B195-marinedrugs-17-00374" ref-type="bibr" class="xref">195</xref>]. This is an important event, because the macular pigments exhibit protective functions against oxidative stress and inflammation, both factors implicated in the pathogenesis of AMD [
 <xref rid="B196-marinedrugs-17-00374" ref-type="bibr" class="xref">196</xref>].
</p>
